Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2011-04-11 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2011
Regulatory Filings
2011-04-11 Danish
AGM Information 2011
AGM Information Classification · 100% confidence The document is explicitly titled "Indkaldelse til ordinær generalforsamling i Blue Vision A/S" (Notice of Annual General Meeting in Blue Vision A/S) and details the agenda (Dagordenen) for the meeting scheduled for April 29, 2011. The agenda items cover standard AGM topics like the Board's report, approval of the annual report, discharge of management, election of the board/auditor, and proposed changes to the articles of association. This content directly corresponds to the definition of AGM Information, which is classified as AGM-R.
2011-04-07 English
AGM Information 2011
AGM Information Classification · 99% confidence The document is dated April 7, 2011, and explicitly announces that 'Blue vision A/S afholder ordinær generalforsamling' (Blue Vision A/S will hold its Annual General Meeting) on April 29, 2011. It then lists the agenda items typical for an AGM, such as the board's report, approval of the annual report, dividend distribution, election of the board, and authorization for share buybacks. This content directly relates to the preparation and announcement of the Annual General Meeting proceedings. Therefore, the classification is AGM Information (AGM-R). The document length is short (948 chars), but it is the primary announcement/material for the meeting itself, not just a notice that a report is attached, making AGM-R more specific than RPA or RNS.
2011-04-07 Danish
Annual Report 2010
Annual Report Classification · 100% confidence The document is titled 'Årsrapport 2010' (Annual Report 2010) for Blue Vision A/S. It contains comprehensive financial statements, including the income statement, balance sheet, cash flow statement, and notes for both the group and the parent company, as well as the auditor's report and management's review. It is a full-year financial report, not an announcement or a summary. FY 2010
2011-03-31 English
Annual Report 2011
Annual Report
2011-03-31 Danish
Share Issue/Capital Change 2011
Share Issue/Capital Change Classification · 99% confidence The document is a short company announcement ("SELSKABSMEDDELELSE") dated March 18, 2011, regarding the listing of new shares resulting from the conversion of convertible debt instruments following a capital increase. It specifically discusses ISIN codes, the date new shares gain dividend rights, and the expected date of final listing on NASDAQ OMX Copenhagen. This content directly relates to changes in the company's capital structure and the issuance of new shares. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not a full report, an earnings release, or a management discussion.
2011-03-18 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.